Retraction Watch

KCL investigation finds misconduct in Lancet Neurology paper

A Lancet journal has issued an expression of concern for a 2019 paper by a group in the United Kingdom whose work was found to have included fabricated data and other misconduct.

The article, “Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study,” came from a team at King’s College London led by researchers at the school’s Neurodegeneration Imaging Group. The senior author on the paper, which appeared in Lancet Neurology, was Marios Politis, who has since left KCL for the University of Exeter.

The study earned press coverage in The Guardian – “Parkinson’s disease ‘could be detected early on by brain changes‘” – and the BBC: “Early brain ‘signs of Parkinson’s’ found.”

Here’s the expression of concern:

Philadelphia-area lung researcher up to six retractions

A lung researcher is up to six retractions for problematic images.

Dilip Shah’s last academic post was at Cooper University Hospital in Camden, N.J., where he worked as a post-doc in the lab of Vineet Bhandari. While there, Shah landed first authorship on a 2020 article in the European Respiratory Journal titled “miR-184 mediates hyperoxia-induced injury by targeting cell death and angiogenesis signalling pathways in the developing lung.”

According to the notice:

Biotech’s ‘cell squeezing’ technology paper earns expression of concern

A 2018 study in PNAS that claimed to show a biotech company’s platform for creating immunotherapies was better than existing methods has earned an expression of concern over the reproducibility of some of its findings.

When the article appeared, STAT called “Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo,” a “major paper that showed more clearly why companies like Roche are so interested in using its technique.”

The technique was developed by SQZ Biotech, which was founded by MIT’s Robert Langer, a founder or co-founder of numerous biotechs including Moderna, and with whom Roche partnered in 2015.

The paper has been cited 55 times, according to Clarivate Analytics’ Web of Science. According to a press release announcing the work:

Weekend reads: ‘Death threats, ghost researchers and sock puppets’; high levels of duplication in Russian science; DNA barcoding fraud?

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured:

Paper used to support claims that ivermectin reduces COVID-19 hospitalizations is withdrawn by preprint server
University president in Japan self-plagiarized and will forfeit some pay
French ocean institute goes public about authors who forged their researchers’ names
Vice chancellor in Pakistan sues researcher whose work he plagiarized – and says he was the victim
Paper overestimated risk of COVID-19 to endangered apes
‘Amateur bullshit’ is the price to pay for democratizing scholarly publishing, says editor
University recommends seven more retractions for psychology researcher

Our list of retracted or withdrawn COVID-19 papers is up to 209. There are now more than 32,000 retractions in our database — which now powers retraction alerts in EndNote, LibKey, Papers, and Zotero. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Paper used to support claims that ivermectin reduces COVID-19 hospitalizations is withdrawn by preprint server

The overseers of the preprint server SocArXiv have withdrawn a paper which claims that treating Covid patients with ivermectin dramatically reduces their odds of hospitalization, calling the work “misleading” and “part of an unethical program by the government of Mexico City to dispense hundreds of thousands of doses of an inappropriate medication to people who were sick with COVID-19.”

“Ivermectin and the odds of hospitalization due to COVID-19: evidence from a quasi-experimental analysis based on a public intervention in Mexico City,” has been a source of controversy for SocArXiv since it was accepted for the site in May 2021.

The paper was written by José Merino, head of the Digital Agency for Public Innovation (DAPI), along with co-authors DAPI, the Mexican Social Security Institute and the Mexico City Ministry of Health. They claimed to find that:

University president in Japan self-plagiarized and will forfeit some pay

The head of a Japanese university has been found guilty of research misconduct for self-plagiarism – technically, duplication – and has agreed to pay a one-time cash penalty for his transgressions.

According to the University of Aizu, a computer science and engineering school in Aizuwakamatsu, Toshiaki Miyazaki, the president and CEO, failed to appropriately cite his own work in four papers:

French ocean institute goes public about authors who forged their researchers’ names

The National Institute for Ocean Science (Ifremer) in France has flagged 11 papers on PubPeer for concerns including faked authorship and plagiarism, and has blasted the journals involved for their failure to adequately address the unethical work.

In some cases, for example the International Journal of Innovative Computing, Information and Control, editors have removed the names of the forged authors without informing readers.

Vice chancellor in Pakistan sues researcher whose work he plagiarized – and says he was the victim

In response to allegations of plagiarism, the vice chancellor of a university in Pakistan has brought a 500 million rupee (~$2,800,000USD) defamation suit against his accuser.

As we reported last July, Farukh Iqbal, of the Department of Chemical and Environmental Engineering at RMIT University, in Melbourne, Australia, had discovered that a paper in the journal Fuel had lifted text from his master’s thesis.

Among the authors was Muhammad Suleman Tahir, the vice chancellor at Khwaja Fareed University of Engineering and Information Technology, in Rahim Yar Khan.

Paper overestimated risk of COVID-19 to endangered apes

Carine06 from UK, CC BY-SA 2.0, via Wikimedia Commons

A Springer Nature journal has retracted a 2021 article with dire news for mountain gorillas in Rwanda’s Volcanoes National Park about the prospects of extinction on the spikes of SARS-CoV-2 after finding a fatal error in their model of the outbreak.

The article, “Exploring the potential effect of COVID-19 on an endangered great ape,” appeared in October in Scientific Reports and was written by a group at the University of Southern Denmark and the the Dian Fossey Gorilla Fund, in Atlanta. The Fund has been concerned – for good reason – about the potential of respiratory illnesses to decimate populations of great apes, whose social nature can foster transmission of infections.

According to the abstract of the paper:

‘Amateur bullshit’ is the price to pay for democratizing scholarly publishing, says editor

A case of author’s remorse immediately after publication of her paper has the editor of the journal calling “bullshit” on the decision to retract the work.

The paper, “Stopping the Revolving Door: Reducing 30-Day Psychiatric Readmissions With Post-discharge Telephone Calls,” was written by a trio of authors from AtlantiCare Regional Medical Center, in southern New Jersey and appeared in Cureus on January 12.

Shortly after publication, the named first author, Antonia Phillip, contacted the journal to repudiate the paper. According to the retraction notice, dated January 14:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: